SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001570562-19-000143
Filing Date
2019-11-04
Accepted
2019-11-04 16:05:23
Documents
60
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q evolus09301910-q.htm 10-Q 1660104
2 EXHIBIT 31.1 exhibit31109301910q.htm EX-31.1 15402
3 EXHIBIT 31.2 exhibit31209301910q.htm EX-31.2 15624
4 EXHIBIT 32.1 exhibit321093019.htm EX-32.1 11856
  Complete submission text file 0001570562-19-000143.txt   6456475

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT eols-20190930.xml EX-101.INS 1101935
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT eols-20190930.xsd EX-101.SCH 46043
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT eols-20190930_cal.xml EX-101.CAL 95002
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT eols-20190930_def.xml EX-101.DEF 206614
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT eols-20190930_lab.xml EX-101.LAB 676234
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT eols-20190930_pre.xml EX-101.PRE 378853
Mailing Address 520 NEWPORT CENTER DRIVE SUITE 1200 NEWPORT BEACH CA 92660
Business Address 520 NEWPORT CENTER DRIVE SUITE 1200 NEWPORT BEACH CA 92660 (949) 284-4555
Evolus, Inc. (Filer) CIK: 0001570562 (see all company filings)

IRS No.: 461385614 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38381 | Film No.: 191189764
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences